BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24200922)

  • 21. Functional significance of brain glycogen in sustaining glutamatergic neurotransmission.
    Sickmann HM; Walls AB; Schousboe A; Bouman SD; Waagepetersen HS
    J Neurochem; 2009 May; 109 Suppl 1():80-6. PubMed ID: 19393012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue-type plasminogen activator is involved in the process of neuronal death induced by oxygen-glucose deprivation in culture.
    Nagai N; Yamamoto S; Tsuboi T; Ihara H; Urano T; Takada Y; Terakawa S; Takada A
    J Cereb Blood Flow Metab; 2001 Jun; 21(6):631-4. PubMed ID: 11488532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α.
    Haile WB; Wu J; Echeverry R; Wu F; An J; Yepes M
    J Cereb Blood Flow Metab; 2012 Jan; 32(1):57-69. PubMed ID: 21792242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue plasminogen activator induces microglial inflammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors.
    Pineda D; Ampurdanés C; Medina MG; Serratosa J; Tusell JM; Saura J; Planas AM; Navarro P
    Glia; 2012 Apr; 60(4):526-40. PubMed ID: 22162045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain.
    Petro M; Jaffer H; Yang J; Kabu S; Morris VB; Labhasetwar V
    Biomaterials; 2016 Mar; 81():169-180. PubMed ID: 26735970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dehydroascorbic Acid Promotes Cell Death in Neurons Under Oxidative Stress: a Protective Role for Astrocytes.
    García-Krauss A; Ferrada L; Astuya A; Salazar K; Cisternas P; Martínez F; Ramírez E; Nualart F
    Mol Neurobiol; 2016 Nov; 53(9):5847-5863. PubMed ID: 26497038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue-type plasminogen activator is a neuroprotectant in the central nervous system.
    Yepes M
    Front Cell Neurosci; 2015; 9():304. PubMed ID: 26347605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
    Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
    J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuation of urokinase activity during experimental ischaemia protects the cerebral barrier from damage through regulation of matrix metalloproteinase-2 and NAD(P)H oxidase.
    Rakkar K; Srivastava K; Bayraktutan U
    Eur J Neurosci; 2014 Jun; 39(12):2119-28. PubMed ID: 24649947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue plasminogen activator contributes to morphine tolerance and induces mechanical allodynia via astrocytic IL-1β and ERK signaling in the spinal cord of mice.
    Berta T; Liu YC; Xu ZZ; Ji RR
    Neuroscience; 2013 Sep; 247():376-85. PubMed ID: 23707980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the GLUT1 Glucose Transporter in Postnatal CNS Angiogenesis and Blood-Brain Barrier Integrity.
    Veys K; Fan Z; Ghobrial M; Bouché A; García-Caballero M; Vriens K; Conchinha NV; Seuwen A; Schlegel F; Gorski T; Crabbé M; Gilardoni P; Ardicoglu R; Schaffenrath J; Casteels C; De Smet G; Smolders I; Van Laere K; Abel ED; Fendt SM; Schroeter A; Kalucka J; Cantelmo AR; Wälchli T; Keller A; Carmeliet P; De Bock K
    Circ Res; 2020 Jul; 127(4):466-482. PubMed ID: 32404031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of alcohol on glucose transport across the blood-brain barrier leads to neurodegeneration: preventive role of acetyl-L: -carnitine.
    Abdul Muneer PM; Alikunju S; Szlachetka AM; Haorah J
    Psychopharmacology (Berl); 2011 Apr; 214(3):707-18. PubMed ID: 21079922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain.
    An J; Zhang C; Polavarapu R; Zhang X; Zhang X; Yepes M
    Blood; 2008 Oct; 112(7):2787-94. PubMed ID: 18628488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular ATP-prinoceptor signaling and AMP-activated protein kinase regulate astrocytic glucose transporter 3 in an in vitro ischemia.
    Iwabuchi S; Kawahara K
    Neurochem Int; 2013 Oct; 63(4):259-68. PubMed ID: 23851016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biphasic regulation of tissue plasminogen activator activity in ischemic rat brain and in cultured neural cells: essential role of astrocyte-derived plasminogen activator inhibitor-1.
    Kim JW; Lee SH; Ko HM; Kwon KJ; Cho KS; Choi CS; Park JH; Kim HY; Lee J; Han SH; Ignarro LJ; Cheong JH; Kim WK; Shin CY
    Neurochem Int; 2011 Feb; 58(3):423-33. PubMed ID: 21193004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zinc-triggered induction of tissue plasminogen activator by brain-derived neurotrophic factor and metalloproteinases.
    Hwang IY; Sun ES; An JH; Im H; Lee SH; Lee JY; Han PL; Koh JY; Kim YH
    J Neurochem; 2011 Sep; 118(5):855-63. PubMed ID: 21615740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via cys-LT1 receptors and mitogen-activated protein kinase pathway.
    Ciccarelli R; D'Alimonte I; Santavenere C; D'Auro M; Ballerini P; Nargi E; Buccella S; Nicosia S; Folco G; Caciagli F; Di Iorio P
    Eur J Neurosci; 2004 Sep; 20(6):1514-24. PubMed ID: 15355318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose transporter 1 and monocarboxylate transporters 1, 2, and 4 localization within the glial cells of shark blood-brain-barriers.
    Balmaceda-Aguilera C; Cortés-Campos C; Cifuentes M; Peruzzo B; Mack L; Tapia JC; Oyarce K; García MA; Nualart F
    PLoS One; 2012; 7(2):e32409. PubMed ID: 22389700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dual role for AMP-activated protein kinase (AMPK) during neonatal hypoxic-ischaemic brain injury in mice.
    Rousset CI; Leiper FC; Kichev A; Gressens P; Carling D; Hagberg H; Thornton C
    J Neurochem; 2015 Apr; 133(2):242-52. PubMed ID: 25598140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of neuronal glucose transporter 3 but not glial glucose transporter 1 following severe diffuse traumatic brain injury in rats.
    Hamlin GP; Cernak I; Wixey JA; Vink R
    J Neurotrauma; 2001 Oct; 18(10):1011-8. PubMed ID: 11686488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.